Asian press release distribution

Press Releases for Wednesday, April 3, 2024

A $45 Billion Dollars Market is in the Crosshairs of BYND Cannasoft with a New Series of Concept Smart Fem-Tech Devices 21:30 HKT/SGT

Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization 20:00 HKT/SGT

Mitsubishi Corporation: Sale of BMA Coal Assets in Queensland Completed 18:05 HKT/SGT

CX Asia Excellence Awards 2024 Opens - Submit Your Entry and Be Recognised as a CX Leader! 17:33 HKT/SGT

Commercial Bank of Dubai (CBD) joins Dubai FinTech Summit as a Strategic Banking Partner 16:53 HKT/SGT

价值增长表现亮眼阳光保险成长性突出可吼 15:58 HKT/SGT

價值增長表現亮眼陽光保險成長性突出可吼 15:55 HKT/SGT

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics 15:24 HKT/SGT

Ensign InfoSecurity showcases AI-powered cyber solutions to combat homeland cybersecurity challenges 14:00 HKT/SGT

天能動力：新能源建設紮實推動科技創新引領產業升級 13:04 HKT/SGT

Capital.com Opens New Regional Head Office in UAE under #NextGenFDI Initiative 13:00 HKT/SGT

天能动力：新能源建设扎实推进科技创新引领产业升级 13:00 HKT/SGT

Tianneng Power: Solid Promotion of New Energy Construction and Technological Innovation Leading Industrial Upgrade 12:55 HKT/SGT

北角汇法国餐厅Briketenia x 日本扭扭棒雕塑家Takuma Fujisaki 11:19 HKT/SGT

北角匯法國餐廳Briketenia x 日本扭扭棒雕塑家Takuma Fujisaki 10:58 HKT/SGT

光大环境以创新驱动转型高质量发展 10:37 HKT/SGT

光大環境以創新驅動轉型高質量發展 10:35 HKT/SGT

阳光保险：核心业务经营稳健 2023年业绩韧性凸显 10:30 HKT/SGT

陽光保險：核心業務經營穩健 2023年業績韌性凸顯 10:28 HKT/SGT

沛嘉醫療(09996.HK)因金融資產評估而停牌 10:23 HKT/SGT

沛嘉医疗(09996.HK)因金融资产评估停牌 10:19 HKT/SGT

Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Financial Results For The Year Ended December 31, 2023 10:00 HKT/SGT

Happy Bermuda Shorts Day, Web 3 Style! 08:21 HKT/SGT

Grifols, S.A. (NASDAQ: GRFS) Short Seller Report: Kaplan Fox Investigates Grifols, S.A. 08:00 HKT/SGT

ACN Search:

CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575